Company Profile
Protagenic Therapeutics Stock Price, News & Analysis
Company overview
Business overview
Protagenic Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Protagenic Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Protagenic Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Protagenic Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Why the stock is moving
PTIX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Protagenic’s catalysts are neuropeptide and CNS programs, with any update that clarifies whether the company can still produce meaningful development progress. The stock needs a cleaner clinical path.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Protagenic's Neuropeptide Shows Strong Efficacy in Treating Depression and Anxiety of Established Rodent Models
Source: Protagenic Therapeutics
- 02
- 03
Protagenic Therapeutics Completes $2.0 Million Convertible Note Financing
Source: Protagenic Therapeutics
- 04
Dr. Maurizio Fava of Massachusetts General Hospital to Serve as Principal Investigator for PT00114 Clinical Trial
Source: Protagenic Therapeutics
- 05
Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering
Source: Protagenic Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.